Publicaciones (25) Publicaciones de MARIA ISABEL ARRIETA SAEZ

2016

  1. Study of the genetic etiology of primary ovarian insufficiency: FMR1 gene

    Genes, Vol. 7, Núm. 12

2015

  1. Evaluation of genotoxic effects of antihypertensive drugs: Angiotensin II receptor blockers

    Antihypertensive Drugs: Pharmacology, Medical Uses and Potential Side Effects (Nova Science Publishers, Inc.), pp. 55-78

2014

  1. Genotoxic evaluation of five Angiotesin II receptor blockers: In vivo and in vitro micronucleus assay

    Mutation Research - Genetic Toxicology and Environmental Mutagenesis, Vol. 767, pp. 1-7

2013

  1. Allelic and genotypic frequencies of platelet glycoprotein polymorphisms in a Portuguese population

    Revista Portuguesa de Cardiologia, Vol. 32, Núm. 2, pp. 111-115

  2. Study of FMR1 gene association with ovarian dysfunction in a sample from the Basque Country

    Gene, Vol. 521, Núm. 1, pp. 145-149

2012

  1. Single Nucleotide Polymorphism and FMR1 CGG Repeat Instability in Two Basque Valleys

    Annals of Human Genetics, Vol. 76, Núm. 2, pp. 110-120

2010

  1. Assessment of the genotoxicity of atenolol in human peripheral blood lymphocytes: Correlation between chromosomal fragility and content of micronuclei

    Mutation Research - Genetic Toxicology and Environmental Mutagenesis, Vol. 695, Núm. 1-2, pp. 46-54

2008

  1. Fragile X gene stability in Basque valleys: Prevalence of premutation and intermediate alleles

    Human Biology, Vol. 80, Núm. 6, pp. 593-600

2004

  1. A new insight into fragile X syndrome among Basque population

    American Journal of Medical Genetics, Vol. 128 A, Núm. 3, pp. 250-255

2003

  1. Dermatoglyphic variation in Spanish Basque populations

    Human Biology, Vol. 75, Núm. 2, pp. 265-291

  2. Haplotypes in the Dystrophin DNA Segment Point to a Mosaic Origin of Modern Human Diversity

    American Journal of Human Genetics, Vol. 73, Núm. 5, pp. 994-1015

  3. The FMR1 CGG repeat and linked microsatellite markers in two Basque valleys

    Heredity, Vol. 90, Núm. 3, pp. 206-211

2002

  1. Chromosomal fragility in a behavioral disorder

    Behavior Genetics, Vol. 32, Núm. 6, pp. 397-412

2001

  1. Determination of the β-blocker atenolol in plasma by capillary zone electrophoresis

    Journal of Chromatography A

  2. Evaluation of the cytogenetic damage induced by the antihypertensive drug nimodipine in human lymphocytes

    Mutagenesis, Vol. 16, Núm. 4, pp. 345-351

2000

  1. In vitro and in vivo evaluation of the antihypertensive drug atenolol in cultured human lymphocytes: Effects of long-term therapy

    Mutagenesis, Vol. 15, Núm. 3, pp. 195-202

1999

  1. A survey of fragile X syndrome in a sample from Spanish Basque country

    Annales de Genetique, Vol. 42, Núm. 4, pp. 197-201

  2. Stability of the FMR1 CGG repeat in a Basque sample

    Human Biology, Vol. 71, Núm. 1, pp. 55-68

1997

  1. Angelman syndrome caused by loss of a marker chromosome: Cytogenetic and fluorescence in situ hybridization analysis

    Psychiatric Genetics, Vol. 7, Núm. 4, pp. 153-158

1996

  1. A case of Prader-Willi syndrome associated with mosaicism: Cytogenetic and FISH study

    Genes and Genetic Systems, Vol. 71, Núm. 1, pp. 31-36